Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Psoriatic Arthritis : At a Glance
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects both the skin and joints, typically developing in individuals with psoriasis. Characterized by joint pain, stiffness, and swelling, PsA can lead to significant disability if not properly managed. It presents in various forms, including symmetrical arthritis, asymmetrical oligoarthritis, and spondylitis, each with distinct clinical features. Early diagnosis is crucial to prevent joint damage and maintain quality of life, as PsA can be progressive and debilitating.
Management of Psoriatic Arthritis involves a combination of treatments aimed at controlling inflammation, reducing pain, and improving joint function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used for mild cases, while disease-modifying antirheumatic drugs (DMARDs) and biologics, such as TNF inhibitors and IL-17 inhibitors, are crucial for more severe cases. Biologics have revolutionized PsA treatment by targeting specific immune pathways involved in the disease process, offering significant improvements in both skin and joint symptoms. Regular monitoring and a multidisciplinary approach are essential to address the diverse manifestations of PsA and to adjust treatment as needed for optimal patient outcomes.
See More Webinars @ Hidoc Webinars
1.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
2.
Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.
3.
AI catches one-third of interval breast cancers missed at screening
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
1.
Lymphomatoid Papulosis: What You Need to Know
2.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
3.
The Rise of Immunotherapy: New Advances in Cancer Treatment
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
Patient Management Following Organ-Preserving Cancer Interventions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation